Insider Trading March 30, 2026

Saba Capital Trims Stake in BlackRock ESG Trust, Sells $1.72M of ECAT Shares

Hedge fund disposes of 126,025 shares across two days as ECAT trades near its 52-week low and yields 24.5%

By Maya Rios ECAT
Saba Capital Trims Stake in BlackRock ESG Trust, Sells $1.72M of ECAT Shares
ECAT

Saba Capital Management, a roughly 10% holder of BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT), sold 126,025 shares of ECAT on March 26-27, 2026, generating $1.72 million in proceeds. The two transactions were executed at prices between $13.87 and $13.59 per share, leaving Saba with 22,284,508 shares after the sales. ECAT is trading at $13.39, close to its 52-week low of $13.35, and yields 24.5%.

Key Points

  • Saba Capital sold a total of 126,025 ECAT shares on March 26-27, 2026, for $1.72 million.
  • After the March 26 sale of 37,606 shares at $13.87, Saba’s holdings were 22,372,927 shares; following the March 27 sale of 88,419 shares at $13.59, holdings fell to 22,284,508 shares.
  • ECAT trades at $13.39, near its 52-week low of $13.35, is down roughly 8% year-to-date, and yields 24.5%.

Saba Capital Management, L.P. — identified as a roughly 10% owner of BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) — reduced its position in the closed-end fund over two trading days at the end of March 2026.

Across March 26 and March 27, Saba Capital sold a combined 126,025 shares of ECAT, realizing total proceeds of $1.72 million. The individual trade prices ranged from $13.59 to $13.87 per share.

On March 26, the firm sold 37,606 shares at $13.87 each. After that transaction, Saba’s reported holdings stood at 22,372,927 shares. The following day, March 27, it executed a larger block sale of 88,419 shares at $13.59 per share, which reduced the firm’s stake to 22,284,508 shares.

Market quotes show ECAT trading at $13.39, marginally above its 52-week low of $13.35. Year-to-date performance for the security is down approximately 8%.

The fund continues to offer a substantial distribution yield, listed at 24.5% in market data. Separate commentary from InvestingPro classifies the stock as being in oversold territory and notes that more detailed analysis and subscriber-only guidance are available to paying users.

No additional commentary from Saba Capital or BlackRock was included in the transaction filings. The public disclosures record the trade sizes, execution prices, and the resulting change in Saba’s holdings without indicating any planned further action.


Context and takeaways

  • Saba Capital executed two sales totaling 126,025 ECAT shares over March 26-27, 2026, for $1.72 million in proceeds.
  • Holdings moved from 22,372,927 shares after the March 26 sale to 22,284,508 shares following the March 27 sale.
  • ECAT is trading near its 52-week low and carries a 24.5% dividend yield according to market data; InvestingPro flags the stock as oversold.

This report is limited to the transaction details disclosed in the filings and the cited market data; it does not include commentary beyond those disclosures.

Risks

  • Market-price risk: ECAT is trading slightly above its 52-week low, indicating limited near-term upside from current market levels.
  • Performance uncertainty: The fund has declined about 8% year-to-date, reflecting short-term negative performance.
  • Concentration risk for large holders: Changes in sizable ownership stakes, such as Saba’s disposition, can influence supply and demand dynamics for the fund’s shares.

More from Insider Trading

Westlake CFO Disposes $1.85 Million in Shares as Stock Nears Yearly Peak Mar 30, 2026 Kopin CEO Executes Small Share Sale as Stock Trades Below Sale Price Mar 30, 2026 AAR Corp Legal Chief Executes Options, Sells Shares Worth $705K Mar 30, 2026 Hercules Capital Director Elects Stock, Buys $104,998 in Shares; Analyst Notes and Loan Update Follow Mar 30, 2026 Saba Capital Expands Stake in Virtus Dividend Fund With $1.99M Purchase Mar 30, 2026